- الرئيسية
- عن الجامعة
- المهند عبدالوهاب محمود الكيال
المهند عبدالوهاب محمود الكيال
السيرة الذاتية
جدول الدراسة
الابحاث والمؤلفات
المشاريع البحثية
الجوائز
A 5-Year Update on the Clinical Development of Cancer Cell-Based Vaccines for Glioblastoma Multiforme
Pharmaceuticals
DOI
10.3390/ph18030376
Advances in immunotherapy for glioblastoma multiforme
Frontiers in Immunology
DOI
10.3389/fimmu.2022.944452
Association of genetic and allelic variants of von Willebrand factor (VWF), glutathione S-transferase and tumor necrosis factor alpha with ischemic stroke susceptibility and …
Life-Basel
DOI
10.3390/life13051200
Construction of VSV?51M oncolytic virus expressing human interleukin-12
Frontiers in Molecular Biosciences
DOI
10.3389/fmolb.2023.1190669
Current insights into diagnosis, prevention strategies, treatment, therapeutic targets, and challenges of monkeypox (Mpox) infections in human populations
Life-Basel
DOI
10.3390/life13010249
Dihydropyrimidone Derivatives as Thymidine Phosphorylase Inhibitors: Inhibition Kinetics, Cytotoxicity, and Molecular Docking
MOLECULES
DOI
10.3390/molecules28083634
Harnessing SARS-CoV-2 immunity to promote antitumor responses through intratumoral vaccination and adoptive transfer
Frontiers in Immunology
DOI
10.3389/fimmu.2026.1711569
Heterologous prime-boost cellular vaccination induces potent antitumor immunity against triple negative breast cancer
Frontiers in Immunology
DOI
10.3389/fimmu.2023.1098344
Identification of Small Molecule Inhibitors Targeting PD-L1 Protein Using Computational Tools and an Experimental Assay
ANTICANCER RESEARCH
DOI
10.21873/anticanres.17733
Immunogenic mutanome of breast cancer: Advances, challenges and future directions in neoantigen-based immunotherapy
Advances in Clinical and Experimental Medicine
DOI
10.17219/acem/205014
Insights from veterinary models for advancing oncolytic virotherapy through comparative oncology
Frontiers in Molecular Biosciences
DOI
10.3389/fmolb.2025.1615393
Integrated In Silico and In Vivo Evaluation of a Tetravalent SARS-CoV-2 RBD–Fc Fusion Vaccine with Broad Cross-Variant Antibody Responses
Vaccines
DOI
10.3390/vaccines13121244
Middle east respiratory syndrome coronavirus infection elicits long-lasting specific antibody, T and B cell immune responses in recovered individuals
CLINICAL INFECTIOUS DISEASES
DOI
10.1093/cid/ciac456
Neoantigen-Encoded Oncolytic Viruses as Personalized Cancer Vaccines
Pharmaceuticals
DOI
10.3390/ph19030364
Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic ductal adenocarcinoma
Frontiers in Oncology
DOI
10.3389/fonc.2023.1071751
Preclinical efficacy of oncolytic VSV-IFN? in treating cancer: A systematic review
Frontiers in Immunology
DOI
10.3389/fimmu.2023.1085940
Reconstruction of the Oncolytic Maraba MG1 Virus from a Fully Synthetic DNA Genome
Journal of Biomaterials and Tissue Engineering
DOI
10.1166/jbt.2023.3276
Repurposing the oncolytic virus VSV? 51M as a COVID-19 vaccine
Frontiers in Bioengineering and Biotechnology
DOI
10.3389/fbioe.2023.1150892
SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus
Frontiers in Immunology
DOI
10.3389/fimmu.2023.1082191
Seroprevalence of SARS-CoV-2 binding and neutralizing antibodies in healthcare workers during the epidemic peak in referral hospitals and quarantine sites: Saudi Arabia
Viruses-Basel
DOI
10.3390/v13071413
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy
Nature Communications
DOI
10.1038/s41467-022-29526-8
Recombinant adenoviruses application for cancer vaccines: from genetic design to clinical translation
Frontiers in Oncology
DOI
10.3389/fonc.2026.1824087
الكلية
كلية العلوم الطبية التطبيقية
التخصص العام
علوم المختبرات الطبية
التخصص الدقيق
الفيروسات الطبية
الدرجة العلمية
دكتوراة
الجنسية
السعودية
المسمى الوظيفي
استاذ مشارك